Iboctadekin
Iboctadekin Uses, Dosage, Side Effects, Food Interaction and all others data.
Iboctadekin is under investigation in clinical trial NCT00500058 (A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18).
| Trade Name | Iboctadekin |
| Generic | Iboctadekin |
| Iboctadekin Other Names | Iboctadekin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Iboctadekin
